Related Experiment Video
Updated: Jun 8, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Quinolone and cephalosporin resistance in enteric Fever
Malini Rajinder Capoor1, Deepthi Nair
1Department of Microbiology, Vardhman Mahaveer Medical College and Safdarjung Hospital, New Delhi, India.
Abstract:
Enteric fever is a major public health problem in developing countries. Ciprofloxacin resistance has now become a norm in the Indian subcontinent. Novel molecular substitutions may become frequent in future owing to selective pressures exerted by the irrational use of ciprofloxacin in human and veterinary therapeutics, in a population endemic with nalidixic acid-resistant strains. The therapeutics of ciprofloxacin-resistant enteric fever narrows down to third- and fourth-generation cephalosporins, azithromycin, tigecycline and penems. The first-line antimicrobials ampicillin, chloramphenicol and co-trimoxazole need to be rolled back. Antimicrobial surveillance coupled with molecular analysis of fluoroquinolone resistance is warranted for reconfirming novel and established molecular patterns for therapeutic reappraisal and for novel-drug targets. This review explores the antimicrobial resistance and its molecular mechanisms, as well as novel drugs in the therapy of enteric fever.
Insights
Enteric fever treatment is challenged by widespread ciprofloxacin resistance in India. Alternative antibiotics and antimicrobial surveillance are crucial for managing this public health issue.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Enteric fever poses a significant public health threat, particularly in developing nations.
- Ciprofloxacin resistance is now prevalent in the Indian subcontinent, complicating treatment options.
- The irrational use of ciprofloxacin contributes to the rise of resistant strains, including nalidixic acid-resistant ones.
Purpose of the Study:
- To review the current landscape of antimicrobial resistance in enteric fever.
- To explore the molecular mechanisms underlying fluoroquinolone resistance.
- To discuss novel therapeutic agents and strategies for managing ciprofloxacin-resistant enteric fever.
Main Methods:
- This review synthesizes existing literature on enteric fever, antimicrobial resistance, and treatment strategies.
- It examines molecular mechanisms of fluoroquinolone resistance.
- It analyzes the efficacy and role of alternative antimicrobial agents.
Main Results:
- Ciprofloxacin resistance is widespread, necessitating a reevaluation of first-line treatments like ampicillin, chloramphenicol, and co-trimoxazole.
- Effective therapeutic options for ciprofloxacin-resistant enteric fever include third- and fourth-generation cephalosporins, azithromycin, tigecycline, and penems.
- Antimicrobial surveillance and molecular analysis are vital for tracking resistance patterns and identifying new drug targets.
Conclusions:
- The emergence of ciprofloxacin resistance demands a shift in therapeutic approaches for enteric fever.
- Continued antimicrobial surveillance and molecular research are essential for guiding treatment and developing new interventions.
- A strategic rollback of older, less effective antimicrobials is recommended.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Bacterial Gastroenteritis
Gene Regulation in Microbial Communities: Quorum Sensing
Stringent Response in E. coli

